[Federal Register Volume 68, Number 163 (Friday, August 22, 2003)]
[Notices]
[Pages 50778-50782]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-21514]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 04011]


Grants for Injury Control Research Centers; Notice of 
Availability of Funds

    Application Deadline: September 22, 2003.

A. Authority and Catalog of Federal Domestic Assistance Number

    This program is authorized under sections 301(a) and 391(a) of the 
Public Health Service Act, (42 U.S.C. sections 280b(a) and 391(a)), as 
amended. The Catalog of Federal Domestic Assistance number is 93.136.

B. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 2004 funds for grants for Injury 
Control Research Centers (ICRC). This program addresses the ``Healthy 
People 2010'' focus area of Injury and Violence Prevention. A copy of 
``Healthy People 2010'' is available at the following Internet address: 
http://www.health.gov/healthypeople.
    The purposes of this program are:
    1. To support injury prevention and control research on priority 
issues as delineated in: ``Healthy People 2010''; ``Reducing the Burden 
of Injury: Advancing Prevention and Treatment''; and the research 
priorities published in the CDC Injury Research Agenda, located at 
http://www.cdc.gov/ncipc.
    2. To integrate, in the context of a national program, the 
disciplines of epidemiology, medicine, biomechanics and other 
engineering, biostatistics, public health, law and criminal justice, 
and behavioral and social sciences in order to prevent and control 
injuries more effectively.
    3. To define the injury problem; identify risk and protective 
factors; develop and evaluate prevention and control interventions and 
strategies; and ensure widespread adoption of effective interventions 
and strategies.
    4. To provide technical assistance to injury prevention and control 
programs within a geographic region.
    Measurable outcomes of the program will be in alignment with the 
following performance goal for the National Center for Injury 
Prevention and Control (NCIPC): Develop new or improved approaches for 
preventing and controlling death and disability due to injuries.

C. Eligible Applicants

    This announcement will provide funding for applicants in regions 
that do not have funded Injury Control Research Centers (ICRCs) and for 
applicants in regions that have funded Centers that must re-compete for 
funding.
    Eligible applicants include nonprofit and for-profit organizations. 
Thus, universities, colleges, research institutions, hospitals, other 
public and private organizations, faith-based organizations, tribal 
organizations, State, Tribal, and local health departments, and small, 
minority and/or women-owned businesses are eligible for these grants. 
Non-academic applicant institutions should provide evidence of a 
collaborative relationship with an academic institution.
    Eligible applicants are limited to organizations in Department of 
Health and Human Services (DHHS) Region II (New Jersey, New York, 
Puerto Rico, and Virgin Islands), Region III (Delaware, District of 
Columbia, Maryland, Pennsylvania, Virginia, and West Virginia), Region 
IV (Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, 
South Carolina, and Tennessee), Region VI (Arkansas, Louisiana, New 
Mexico, Oklahoma, and Texas), Region IX (Arizona, California, Hawaii, 
Nevada, American Samoa, Guam, Mariana Islands, Marshall Islands, 
Micronesia, and Palau), and Region X (Alaska, Idaho, Oregon, and 
Washington).

    Note: ICRC grant awards are made to the applicant institution/
organization, not the Principal Investigator. Title 2 of the United 
States Code section 1611 states that an organization described in 
section 501(c)(4) of the Internal Revenue Code that engages in 
lobbying activities is not eligible to receive Federal funds 
constituting an award, grant or loan.

B. Funding

Availability of Funds

    Approximately $4,527,500 is expected to be available in FY 2004 to 
fund five awards. It is expected that each award will be $905,500 
(total of direct and indirect costs). Applicants will be allowed to 
apply for $1,055,500 ($150,000 above the expected award amount to allow 
for the inclusion of the description of an additional large project as 
described in Section F. Content 4.b. (2).), but each award will be no 
more than $905,500 (total of direct and indirect costs). It is expected 
that each award will begin on or about September 1, 2004, and will be 
made for a 12-month budget period within a project period of up to five 
years. Applications that exceed the funding cap noted above will be 
excluded from the competition and returned to the applicant. Funding 
estimates may change.
    Consideration will also be given to current grantees that submit a 
competitive supplement requesting one year of funding to enhance or 
expand existing projects, or to conduct one-year pilot studies. These 
awards will not exceed $150,000, including both direct and indirect 
costs. Supplemental awards will be made for the budget period to 
coincide with the actual budget period of the grant and are based on 
the availability of funds.
    Continuation awards within an approved project period will be made 
on the basis of satisfactory progress as evidenced by required reports 
and the availability of funds.

Use of Funds

    Center funding is to be designated for two types of activities. One 
type of activity is considered core and includes administration, 
management, general support services (e.g., statistical, library, media 
relations, and advocacy) as well as activities associated with research 
development, technical assistance, and education (e.g., seed projects, 
training activities, and collaborative and technical assistance 
activities with other groups). Funds may be allocated for trainee 
stipends, tuition remission, and trainee travel in accordance with the 
current rates for the United States Public Health Service agencies. 
Indirect costs for these trainee-related activities are limited to 
eight percent.
    Defined research projects constitute the second type of activity, 
and ICRCs are encouraged to work toward addressing the breadth of the 
field. Core activities and defined research projects may each 
constitute between 25 percent and 75 percent of the operating budget, 
and should be balanced in such a way that the ICRC demonstrates 
productivity in research as well as teaching and service. Applicants 
with less demonstrated expertise in research are encouraged to devote a 
larger percentage of funds to defined research projects in order to 
establish their capability as research centers of excellence.
    Grant funds will not be made available to support the provision of 
direct care. Studies may be supported

[[Page 50779]]

which evaluate methods of acute care and rehabilitation for potential 
reductions in injury effects and costs. Studies may be supported which 
identify the effect on injury outcomes and cost of systems for pre-
hospital, hospital, and rehabilitative care and independent living.
    Eligible applicants may enter into contracts, including consortia 
agreements (as set forth in the PHS Grants Policy Statement, dated 
April 1, 1994), as necessary to meet the requirements of the program 
and strengthen the overall application.

Funding Preferences

    At the discretion of the Director, NCIPC, additional consideration 
may be given to re-competing ICRCs. These centers represent a long-term 
investment for NCIPC and an established resource for injury control-
related issues for their States and regions.

Recipient Financial Participation

    Matching funds are not required for this program announcement, 
however other sources of funding must be documented.

E. Program Requirements

    In conducting activities to achieve the purpose of this program, 
applicants will be responsible for the following activities.
    1. Applicants must demonstrate expertise and experience in 
conducting and publishing injury research in at least one of the three 
phases of injury control (prevention, acute care, or rehabilitation) 
and are encouraged to be comprehensive.
    2. Applicants must document ongoing injury control-related research 
projects and activities currently supported by other sources of 
funding.
    3. Applicants must provide a director (Principal Investigator) who 
has specific authority and responsibility to carry out the project. The 
director must report to an appropriate institutional official, e.g., 
dean of a school, vice president of a university, or commissioner of 
health. The director must have no less than thirty percent effort 
devoted solely to this project with an anticipated range of thirty 
percent to fifty percent.
    4. Applicants must provide evidence of working relationships, 
including consultation and technical assistance, with outside agencies 
and other entities in the region in which the ICRC is located which 
will allow for implementation and evaluation of any proposed 
intervention activities.
    5. Applicants must provide evidence of involvement of specialists 
or experts in medicine, biomechanics and other engineering, 
epidemiology, law and criminal justice, behavioral and social sciences, 
biostatistics, and public health as needed to complete the plans of the 
center. These are considered the disciplines and fields for ICRCs.
    6. Applicants must have established curricula and graduate training 
programs in disciplines relevant to injury control (See Section E.5).
    7. Applicants must disseminate injury control research findings, 
translate them into interventions (i.e., programs or policies), and 
evaluate their effectiveness.

F. Content

Letter of Intent (LOI)

    A LOI is strongly encouraged for this program. The program 
announcement title and number must appear in the LOI. The narrative 
should be no more than two single-spaced pages, printed on one side, 
with one-inch margins, and unreduced 12-point font. The letter should 
identify the name of the principal investigator, and briefly describe 
the scope and intent of the proposed research work. The letter of 
intent does not influence review or funding decisions, but the number 
of letters received will enable CDC to plan the review more effectively 
and efficiently.

Application

    The Program Announcement title and number must appear in the 
application. Use the information in the Program Requirements, Other 
Requirements, and Evaluation Criteria sections to develop the 
application content. Applications should include the following 
information, detailing activities to be conducted for the first budget 
year, while briefly addressing activities to be conducted over the 
entire five-year project period.
    1. Face page
    2. Description (abstract) and personnel
    3. Table of contents
    4. Detailed budget for the initial budget period: The budget should 
reflect the composite figures for the grant. In addition, separate 
budgets (direct and indirect costs) and justifications should be 
provided for the following categories of activities:
    a. Core activities, including management and administrative 
functions, other non-research activities (e.g., education/training, 
consultation, technical assistance, translation/dissemination, program 
and policy development and evaluation, advocacy, and media activities, 
etc.), and small seed projects of less than $25,000 (total of direct 
and indirect costs) for one year or less.
    b. Research Studies:
    (1) Small studies of $25,000-150,000/year (total of direct and 
indirect costs) for one to three years duration. These projects might 
be expansions of seed projects, either further developing methods or 
hypotheses in preparation for a larger investigation leading to the 
submission of an RO1 level proposal, or might be stand-alone 
investigations sufficient to yield results worthy of publication in a 
peer-reviewed journal and/or a technical report for a legislative body, 
governmental agency, or injury control program.
    (2) Larger scale studies with annual budgets exceeding $150,000/
year (total of direct and indirect costs) and lasting up to five years. 
These projects typically will test hypotheses and employ more 
sophisticated methodologies and/or larger sample sizes than small 
studies.
    For seed projects, only modest budget descriptions are required 
within the application. More detailed budget descriptions, commensurate 
with costs, are required for both small studies and large research 
projects.
    An applicant organization has the option of having specific salary 
and fringe benefit amounts for individuals omitted from the copies of 
the application that are made available to outside reviewing groups. To 
exercise this option: on the original and two copies of the 
application, the applicant must use asterisks to indicate those 
individuals for whom salaries and fringe benefits are not shown; the 
subtotals must still be shown. In addition, the applicant must submit 
an additional copy of page four of Form PHS-398, completed in full, 
with the asterisks replaced by the salaries and fringe benefits. This 
budget page will be reserved for internal staff use only.
    5. Budget for entire proposed project period including budgets 
pertaining to consortium/contractual arrangements.
    6. Biographical sketches of key personnel, consultants, and 
collaborators, beginning with the Principal Investigator and core 
faculty.
    7. Other support: This listing should include all other funds or 
resources pending or currently available. For each grant or contract 
include source of funds, amount of funding (indicate whether pending or 
current), date of funding (initiation and termination), and 
relationship to the proposed program.
    8. Resources and environment.
    9. Research plan:
    a. ICRCs are to develop a range of research and other non-research

[[Page 50780]]

activities that are designed to advance the field of injury control 
through development of new scientific or surveillance methods, creation 
of new knowledge, and translation of knowledge into training, program 
and policy development and evaluation activities or other applications 
that will ultimately reduce injuries or their effects. ICRC 
applications should articulate how the activities of their program are 
integrated with each other.
    b. A detailed research plan (design and methods), in accordance 
with NCIPC's performance goal as stated in section ``B. Purpose'', 
including hypothesis, expected outcome, value to the field, and 
measurable and time-framed objectives consistent with the activities 
for each project within the proposed grant.
    (1) Initial seed projects require a short write-up describing the 
injury control context of the study, the objective, the design, the 
setting and participants, the intervention being addressed, main 
outcome measurements, expected results, time lines, cost (total of 
direct and indirect costs), plans for translation/dissemination, and 
clear definition of procedures used to select the projects. Clear 
definitions of procedures used to select future out-year seed projects 
are also required.
    (2) Small research projects require a ten to fifteen page summary 
describing the accomplishment of all the steps, including a description 
of the significance of the project, the development and testing of 
methods and instruments, and the collection of preliminary data needed 
to take an innovative approach and develop it to the level of a larger 
investigation leading to the submission of an RO1 level proposal or a 
stand-alone investigation sufficient to yield results worthy of 
publication in a peer-reviewed journal and/or a technical report for a 
legislative body, governmental agency, or injury control program.
    (3) Large research projects require an RO1 level summary as 
described in the PHS 398 (Revised 5/01 and updated 6/28/02) guidelines 
(See Attachment 2, as posted on the CDC website). The summary should be 
included as an appendix of the application.
    In the research plan section of the application include a 
description for each small and large research project:
    (a) Title of Project
    (b) Project Director/Lead Investigator
    (c) Institution(s)
    (d) Categorization as Prevention, Acute Care, Rehabilitation, or 
Biomechanics
    (e) Categorization as to which NCIPC research agenda priority area 
the project addresses. Also, a brief description on how it addresses 
that priority area. If a priority area is not addressed, provide an 
explanation of why it is important.
    (f) Categorization as Seed Project, Small Project, or Large Project
    (g) Categorization as New or Ongoing Project
    (h) Cost/Year (total of direct and indirect costs)
    (i) Research Training: Names, Degrees of Persons Trained or in 
Training
    (j) Key Words
    (k) Brief Summary of Project including Intended Application of 
Finding (Abstract)
    c. A description of the core faculty and their roles in 
implementing and evaluating the proposed programs. The applicant should 
clearly specify how disciplines will be integrated to achieve the ICRCs 
objectives.
    d. Charts showing the proposed organizational structure of the ICRC 
and its relationship to the broader institution of which it is a part 
and, where applicable, to affiliate institutions or collaborating 
organizations. These charts should clearly detail the lines of 
authority as they relate to the center, both structurally and 
operationally. ICRC directors should report to an appropriate 
organizational level (e.g. dean of a school, vice president of a 
university, or commissioner of health), demonstrating strong 
institution-wide support of ICRC activities and ensuring oversight of 
the process of interdisciplinary activity.
    e. Documentation of the public health agencies and other public and 
private sector entities to be involved in the proposed program, 
including letters that detail commitments of support and a clear 
statement of the role, activities, and participating personnel of each 
agency or entity.
    Beginning October 1, 2003, applicants will be required to have a 
Dun and Bradstreet (DUNS) number to apply for a grant or cooperative 
agreement from the Federal government. The DUNS number is a nine-digit 
identification number, which uniquely identifies business entities. 
Obtaining a DUNS number is easy and there is no charge.
    You are encouraged to obtain a DUNS now if you believe you will be 
submitting an application to any Federal agency on or after October 1, 
2003. Proactively obtaining a DUNS number at the current time will 
facilitate the receipt and acceptance of applications after September 
2003.
    To obtain a DUNS number, access the following web site: 
www.dunandbradstreet.com OR call 1-866-705-5711.

G. Submission and Deadline

Letter of Intent (LOI) Submission

    On or before September 8, 2003, submit the LOI to the Grants 
Management Specialist identified in the ``Where to Obtain Additional 
Information'' section of this announcement.

Application Forms

    Submit the original and two copies of PHS 398 (OMB Number 0925-
0001) and one electronic disk copy and adhere to the instructions on 
the Errata Instruction sheet for PHS 398. Forms are available at the 
following Internet address: www.cdc.gov/od/pgo/forminfo.htm.
    If you do not have access to the Internet, or if you have 
difficulty accessing the forms on-line, you may contact the CDC 
Procurement and Grants Office Technical Information Management Section 
at: 770-488-2700. Application forms can be mailed to you.

Submission Date, Time, and Address

    The application must be received by 4:00 p.m. Eastern Time, 
November 20, 2003. Submit the application to: Technical Information 
Management Section-PA04011-CDC Procurement and Grants Office, 2920 
Brandywine Road, Atlanta, Georgia 30341. Applications may not be 
submitted electronically.

CDC Acknowledgment of Application Receipt

    A postcard will be mailed by PGO-TIM, notifying you that CDC has 
received your application.

Deadline

    Letters of intent and applications shall be considered as meeting 
the deadline if they are received before 4 p.m. Eastern Time on the 
deadline date. Applicants sending applications by the United States 
Postal Service or commercial delivery services must ensure that the 
carrier will be able to guarantee delivery of the application by the 
closing date and time. If an application is received after closing due 
to (1) carrier error, when the carrier accepted the package with a 
guarantee for delivery by the closing date and time, or (2) significant 
weather delays or natural disasters, CDC will upon receipt of proper 
documentation, consider the application as having been received by the 
deadline.
    Any application that does not meet the above criteria will not be 
eligible for competition, and will be discarded. The applicant will be 
notified of their failure to meet the submission requirements.

[[Page 50781]]

A. Evaluation Criteria

Application

    Applications will be reviewed by CDC staff for completeness and 
responsiveness as outlined under the previous heading Program 
Requirements. Incomplete applications and applications that are not 
responsive will be returned to the applicant without further 
consideration.
    Applications which are complete and responsive will be subjected to 
a preliminary evaluation (streamline review) by the Injury Research 
Grant Review Committee (IRGRC) to determine if the application is of 
sufficient technical and scientific merit to warrant further review by 
the IRGRC. Applications that are determined noncompetitive will not be 
considered, and NCIPC will promptly notify the investigator/program 
director and the official signing for the applicant organization. 
Applications determined to be competitive will be evaluated by a dual 
review process.
    Competing supplemental grant awards may be made, when funds are 
available, to support research work or activities not previously 
approved by the IRGRC. Applications should be clearly labeled to denote 
their status as requesting supplemental funding support. These 
applications will be reviewed by the IRGRC and the secondary review 
group.
    Awards will be made based on priority scores assigned to 
applications by the IRGRC, programmatic priorities and needs determined 
by a secondary review committee (the Advisory Committee for Injury 
Prevention and Control), and the availability of funds.
1. Review by IRGRC
    An initial streamline peer-review of ICRC grant applications will 
be conducted by the IRGRC. The IRGRC may recommend the application for 
a site visit review. For those applications recommended for a site 
visit review, a team of peer reviewers, including members of the IRGRC, 
will conduct on-site visits at each applicant institution, generate 
summary statements for the visits, and report the assessment to the 
IRGRC.
    Factors to be considered by the IRGRC include:
    a. The specific aims of the application, e.g., the long-term 
objectives and intended accomplishments. Approval of small and large 
research projects (including new research projects proposed during the 
five-year funding cycle), in accordance with NCIPC's performance goal 
as stated in section ``B. Purpose'', is subject to peer review.
    (1) Seed projects will be evaluated collectively on the mechanism 
for solicitation of projects and on their technical/scientific merit 
review. Evaluation criteria have equal value.
    (2) Small projects will be evaluated individually on the 
significance of the project, the innovative approach, and the proposed 
methods for achieving an investigation sufficient to support a 
submission of an RO1 level proposal and/or worthy of publication in a 
peer-reviewed journal and/or a technical report for a legislative body, 
governmental agency, or injury control program.
    (3) Large projects will be evaluated individually according to 
existing RO1 level project standards as described in the PHS 398 
(Revised 5/01 and updated 6/28/02) guidelines (See Attachment 2, as 
posted on the CDC website). The application must have a minimum of one 
large research project approved in order to be recommended for further 
consideration.
    (4) At least 80 percent of the costs (total direct and indirect 
costs) of the approved small and large research projects must be in 
alignment with the ``CDC Injury Research Agenda,'' http://www.cdc.gov/ncipc in order to be recommended for further consideration.
    b. The scientific and technical merit of the overall application, 
including the significance and originality (e.g., new topic, new 
method, new approach in a new population, or advancing understanding of 
the problem) of the proposed research.
    c. The extent to which the evaluation plan will allow for the 
measurement of progress toward the achievement of stated objectives. 
Does the application specify how the effectiveness of the program will 
be measured?
    d. Qualifications, adequacy, and appropriateness of personnel to 
accomplish the proposed activities.
    e. The soundness of the proposed budget in terms of adequacy of 
resources and their allocation.
    f. In addition to conducting defined research projects, ICRCs are 
expected to devote substantial attention to advancing the field through 
other activities that are designed to improve research capabilities and 
translate research into practice. Examples of activities include: 
consultation and technical assistance that are responsive to regional, 
State, national, or international priorities; professional training for 
researchers and practitioners; program development; and evaluation 
endeavors. The degree of effort devoted to these aspects of an ICRCs 
program should be clearly stated in the justification and the budget. 
The degree of effort may be varied and should reflect the specific 
focus and goals of the ICRC.
    g. Details of progress in the most recent funding period should be 
provided in the application if the applicant is submitting a re-
competing application. Documented examples of success include: 
development of pilot projects; completion of high quality research 
projects; publication of findings in peer reviewed scientific and 
technical journals; number of professionals trained; awards received; 
ongoing provision of consultation and technical assistance; integration 
of disciplines; translation of research into implementation; and impact 
on injury control outcomes including legislation, regulation, 
treatment, and behavior modification interventions.
    h. Does the application adequately address the requirements of 
Title 45 CFR Part 46 for the protection of human subjects?
    i. Does the applicant meet the CDC Policy requirements regarding 
the inclusion of women, ethnic, and racial groups in the proposed 
research? This includes:
    (1) The proposed plan for the inclusion of both sexes, racial and 
ethnic minority populations for appropriate representation.
    (2) The proposed justification when representation is limited or 
absent.
    (3) A statement as to whether the design of the study is adequate 
to measure differences when warranted.
    (4) A statement as to whether the plans for recruitment and 
outreach for study participants include the process of establishing 
partnerships with community or communities and recognition of mutual 
benefits.
    j. Does the application adequately address the requirements of the 
``PHS Policy on Humane Care and Use of Laboratory Animals by Awardee 
Institutions?''
    k. Does the application include measures that are in accordance 
with CDC's performance plans?
2. Review by the CDC Advisory Committee for Injury Prevention and 
Control (ACIPC)
    Secondary review of ICRC grant applications with a priority score 
of 350 or better from the initial peer-review by the IRGRC will be 
conducted by the Science and Program Review Section (SPRS) of the 
ACIPC. The SPRS consists of ACIPC members, Federal Ex Officio 
participants, and organizational liaisons. The Federal Ex Officio 
participants will be responsible for

[[Page 50782]]

identifying proposals in overlapping areas of research interest so that 
unwarranted duplication in federally funded research can be avoided. 
The NCIPC Division Associate Directors for Science (ADS) or their 
designees will address the SPRS to assure that research priorities of 
the announcement are understood and to provide background regarding 
current research activities. The SPRS recommendations will be presented 
to the entire ACIPC in the form of a report by the Chairman of the 
SPRS. The ACIPC will vote to approve, disapprove, or modify these 
recommendations for funding consideration.
    Factors to be considered by the ACIPC include:
    a. The results of the peer-review.
    b. The significance of the proposed activities as they relate to 
national program priorities, geographic balance, and the achievement of 
national objectives.
    c. The overall balance of the ICRC program in addressing the three 
phases of injury control (prevention, acute care, and rehabilitation); 
the control of injury among populations who are at increased risk, 
including racial/ethnic minority groups, the elderly and children; the 
major causes of intentional and unintentional injury; and the major 
disciplines of injury control.
    d. Budgetary considerations. The ACIPC will recommend annual 
funding levels as detailed in section ``D. Funds'' of this 
announcement.
    These recommendations, based on the results of the peer review by 
the IRGRC, the relevance and balance of the proposed research relative 
to the NCIPC programs and priorities, and the assurance of no 
duplication of federally-funded research, are presented to the 
Director, NCIPC, for funding decisions.
3. Continued Funding
    Continuation awards within the project period will be made on the 
basis of the availability of funds and the following criteria:
    a. The accomplishments of the current budget period show that the 
applicant's objectives as prescribed in the yearly work plans are being 
met.
    b. The objectives for the new budget period are realistic, 
specific, and measurable.
    c. The methods described will clearly lead to achievement of these 
objectives.
    d. The evaluation plan allows management to monitor whether the 
methods are effective by having clearly defined process, impact, and 
outcome objectives, and the applicant demonstrates progress in 
implementing the evaluation plan.
    e. The budget request is clearly explained, adequately justified, 
reasonable, and consistent with the intended use of grant funds.

I. Other Requirements

Technical Reporting Requirements

    Provide CDC with the original plus two copies of:
    1. Annual progress report. The progress report will include a data 
requirement that demonstrates measures of effectiveness.
    2. Financial status report, no more than 90 days after the end of 
the budget period.
    3. Final financial status report and performance report, no more 
than 90 days after the end of the project period.
    Send all reports to the Grants Management Specialist identified in 
the ``Where to Obtain Additional Information'' section of this 
announcement.
    The following additional requirements are applicable to this 
program. For a complete description of each, see Attachment 1 of this 
announcement as posted on the CDC home Web site.

AR-1 Human Subjects Certification
AR-2 Requirements for inclusion of Women and Racial and Ethnic 
Minorities in Research
AR-3 Animal Subjects Requirements
AR-10 Smoke-Free Workplace Requirement
AR-11 Healthy People 2010
AR-12 Lobbying Restrictions
AR-13 Prohibition on Use of CDC funds for Certain Gun Control 
Activities
AR-20 Conference Activities within Grants/Cooperative Agreements
AR-21 Small, Minority, and Women-owned Business
AR-22 Research Integrity

    Executive Order 12372 does not apply to this program.

J. Where To Obtain Additional Information

    This and other CDC announcements can be found on the CDC home page 
Internet address--http://www.cdc.gov. Click on ``Funding'' then 
``Grants and Cooperative Agreements''.
    For general questions about this announcement, contact: Technical 
Information Management, CDC Procurement and Grants Office, 2920 
Brandywine Rd Atlanta, GA 30341-4146, Telephone: 770-488-2700.
    For business management and budget assistance, contact: Nancy 
Pillar, Grants Management Specialist, CDC Procurement and Grants Office 
2920 Brandywine Rd, Atlanta, GA 30341-4146, Telephone: 770-488-2721, E-
mail: [email protected].
    For business management and budget assistance in the territories, 
contact:
    Charlotte Flitcraft, CDC Procurement and Grants Office 2920 
Brandywine Rd., Atlanta, GA 30341-4146, Telephone: 770-488-2780, E-
mail: [email protected].
    For program technical assistance, contact: Tom Voglesonger, Program 
Manager, Office of the Associate Director for Science, National Center 
for Injury Prevention and Control, Centers for Disease Control and 
Prevention (CDC), 4770 Buford Highway, NE., (K58), Atlanta, GA 30341-
3724, Telephone: 770-488-4823, E-mail: [email protected].

    Dated: August 18, 2003.
Sandra R. Manning,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention.
[FR Doc. 03-21514 Filed 8-21-03; 8:45 am]
BILLING CODE 4163-18-P